Blood cells and vascular endothelium

Blood cells and vascular endothelium refers to the collective cellular components of the circulatory system, including erythrocytes, leukocytes, platelets, and the monolayer of endothelial cells lining the vasculature (StatPearls, 2023). This entry does not represent a single molecular target but rather a complex physiological environment and tissue compartment where numerous therapeutic interventions occur (NIH, 2022). The vascular endothelium acts as a dynamic interface regulating blood flow, leukocyte trafficking, and coagulation, while blood cells perform vital functions in gas exchange and systemic immunity (PubMed, PMID: 30241606). Dysregulation within this system is central to the pathogenesis of atherosclerosis, hypertension, sepsis, and various hematological disorders (Wikipedia, 2024). Pharmacological agents often target specific receptors or enzymes within these cells, such as VEGF receptors on endothelial cells or cyclooxygenase in platelets, to treat cardiovascular and inflammatory diseases (PubChem). Because this term encompasses multiple cell types and hundreds of potential molecular targets, it is classified as a tissue-level descriptor rather than a specific therapeutic target.

Other names

Hematopoietic cells and vascular liningHeme-vascular systemCirculatory system cells

Drugs interacting with this system function through diverse mechanisms, including the inhibition of platelet aggregation (e.g., COX-1 inhibition), anticoagulation via thrombin or Factor Xa inhibition, modulation of endothelial nitric oxide production, and antagonism of vascular growth factor receptors (e.g., VEGFR).